ESSA Pharma (EPIX) Reports Results from Phase 1 Trial of EPI-506 for Treatment of mCRPC; Provides Update on Clinical and Strategic Plans Sep 11, 2017 07:33AM
ESSA Pharma Announces Results from the Phase 1 Clinical Trial of EPI-506 for Treatment of mCRPC and Updates Clinical and Strategic Plans Sep 11, 2017 07:30AM